Schedule 13G ownership disclosure
TRAWS PHARMA INC
Common stock, par value $.01 per share · CUSIP: 68232V884
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Ikarian Capital, LLC
Shares: 394,255 · Class: 9.99%
- Neil Shahrestani
Shares: 394,255 · Class: 9.99%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-020854
- Form type
- SCHEDULE 13G
- Filer
- Ikarian Capital, LLC
- CIK
- CIK 1778253
- Filed
- Feb 14, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership